Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2010-04-30 Director's Dealing
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2010-04-30 English
JOHNSON & JOHNSON 8-K 04-22-2010
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed by Johnson & Johnson, dated April 22, 2010. It reports the submission of matters to a vote of security holders at the annual meeting, including election of directors, ratification of the auditor, and shareholder proposals. It also announces a dividend increase. The document contains detailed voting results and dividend declaration information. Form 8-K is a current report used to disclose significant events, including voting results and dividend announcements. The presence of detailed voting results aligns with Declaration of Voting Results & Voting Rights Announcements (DVA). The dividend increase announcement also fits within DVA as it relates to shareholder distributions. The document is 4285 characters, which is relatively short but contains substantive voting data and dividend details, not just a notice or link to a report. Therefore, the best classification is DVA.
2010-04-26 English
Earnings Release 2010
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions "Item 2.02 Results of Operations and Financial Condition" and includes a press release announcing sales and earnings for the first quarter ended April 4, 2010. It also references unaudited supplementary sales data and condensed consolidated statement of earnings for the first quarter. The document length is 2338 characters, which is relatively short and consistent with an earnings release announcement rather than a full quarterly report. The presence of a press release and summary financial data in an 8-K filing aligns with the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. Therefore, the document should be classified as an Earnings Release (ER).
2010-04-20 English
PRIMARY DOCUMENT
Director's Dealing
2010-04-15 English
PRIMARY DOCUMENT
Director's Dealing
2010-04-09 English
PRIMARY DOCUMENT
Director's Dealing
2010-04-02 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.